Sulfonylureas: Major effect: stimulate insulin secretion
First generation
- tolbutamide (Orinase), tolazamide (Tolinase), acetohexamide (Dymelor)
- chlorpropamide (Diabinese)
Second generation
- glyburide: (Micronase Ph-Upj/Diabeta HMR /generic) 1.25, 2.5, 5 mg (s) micronized glyburide (Glynase Pharmacia-Upj/generic) 1.5, 3, 6 mg (s)
- glipizide: (Glucotrol Pfizer/generic) 5, 10 mg (s) GITS (extended release) (Glucotrol XL Pfizer) 2.5, 5, 10 mg
- glimepiride (Amaryl HMR) 1, 2, 4 mg (s)
Meglitinides: Major effect: stimulate insulin secretion (short-acting)
- repaglinide (Prandin NovoN) 0.5, 1, 2 mg
- nateglinide (Starlix Novartis) 60, 120 mg
Biguanides: Major effect: decrease hepatic glucose production
- metformin (Glucophage BMS) 500, 850,1000 mg; Glucophage XR 500mg
alpha-Glucosidase inhibitors: Major effect: slow absorption of starches
- acarbose (Precose Bayer) 50, 100 mg
- miglitol (Glyset Pharmacia-Upj) 25, 50, 100 mg
Thiazolidinediones: Major effect: decrease peripheral insulin resistance
- rosiglitazone (Avandia SKB) 2, 4, 8 mg
- pioglitazone (Actos Takeda/Lilly) 15, 30, 45 mg
Dipeptidyl peptidase inhibitors Major effect: increase incretin levels
- sitagliptin
- saxagliptin
Combination:
- glyburide + metformin (Glucovance BMS) 1.25/250, 2.5/500, 5/500 mg
- other combinations are available
Long-acting:
- insulin glargine (Lantus Aventis)
- insulin detemir (Levemir NovoNordisk)
Intermediate:
- NPH (Neutral Protamine Hagedorn) (Humulin N or Novolin N)
Short-acting:
- insulin lispro (Humalog Lilly)
- insulin aspart (Novolog NovoNordisk)
- insulin glulisine (Apidra Aventis)
Mixes:
- NPH/regular: 70/30, 50/50
- NPH/lispro: (Humalog Mix Lilly) 75/25
- incretin mimetics
- amylin analogues